Table 1.
Modulator | Main Cell Source | Type and Function | Clinical Feature | Reference | |
---|---|---|---|---|---|
Cytokines | |||||
IL-6 | Macrophage, monocyte, activated T cell, dendritic cell, Th2, epithelial cell, endothelium cell, fibroblast | Proinflammatory cytokine; pyrogenic and antibody-enhancing function; induces acute-phase reactants Key player in COVID-19 pathology (neutrophils’ chemotaxis, lymphocytes exhaustion, and lymphocyte necrosis) and its exacerbated inflammatory responses; serum circulation positively correlates with disease severity; negative regulate T cell by increasing the exhaustion markers; main player in cytokine storms |
Body | Fever, anemia, vascular leakage, interstitial edema, myocardial dysfunction, cardiomyopathy, complement & coagulation cascade activation, diffused intravascular coagulation; shock, respiratory failure, multiorgan dysfunction | (4, 6, 8, 9, 20, 22–24, 28, 36–39, 58, 65–88) |
Lung | Acute respiratory distress syndrome (ARDS), endothelial dysfunction, thrombin formation, and impaired fibrinolysis | ||||
Kidney | Acute kidney injury | ||||
Liver | Increased acute-phase protein | ||||
IL-1β | Macrophage, monocyte, endothelium cell, activated T cell, dendritic cell | Inflammasome-induced cytokine May correlate with inflammation intensity and Th1 cell activation; activates and increases IL-6 production; dysfunction drives macrophage activation syndrome |
Body | Fever | (4, 6, 8, 9, 12, 28, 67, 68, 77, 78, 89–92) |
Lung | ARDS | ||||
Liver | Increased acute-phase protein | ||||
IL-18 | Th1, endothelium cell, fibroblast, activated T cell, macrophage | Proinflammatory cytokine; regulates both Th1 and Th2 responses Associates with type I interferon in COVID-19; serum concentration correlates with increase in pneumonia severity |
Lung | ARDS | (8, 12, 68, 93, 94) |
Liver | Liver damage | ||||
IL-10 | Macrophage, monocyte, Th1 and Th2 | Anti-inflammatory cytokine; inhibits Th1 cells and cytokine release Associated with COVID-19 severity; negative regulation of T cells by an increase of exhaustion markers; may expand cytotoxic effector CD8+ T cells, causes hyperactivation of adaptive immunity; high concentrations correlate with low viral load. |
Lung | ARDS | (70–72, 77, 79–81, 95–99) |
Liver | Increased acute-phase protein | ||||
IL-17 | Macrophage, iNKT cell, Th17, neutrophil | Proinflammatory cytokine; neutrophilic inflammation-promoting cytokine Associates with Th17 responses, viral load, severity of disease in COVID-19 |
Lung | Acute lung injury, ARDS | (37, 79, 98, 100–102) |
IFN-γ | Macrophage, Th1 cell, Th17 cell, CD8+ T cell, CD4+ T cell, dendritic cell, NK cell | Proinflammatory cytokine; activates macrophages Impaired activity in severe disease; increased levels strongly correlate with Th1 cell activation |
Body | Fever, impaired hematopoietic function, disseminated intravascular coagulation, decreased serum protein, headaches, chills, fatigue, malaise, cardiomyopathy, vascular leakage, production of acute-phase protein. | (4, 9, 12, 28, 36, 68–70, 72, 76, 77, 79, 101, 103–106) |
Lung | ARDS, lung injury | ||||
TNF-α | Macrophage, monocyte, Th1, Th17, CD8+ T cell, dendritic cell, epithelial cell, endothelium cell | Pyrogenic cytokine; increases vascular permeability Impaired activity in severe patients with COVID-19; increases IL-6 production; main contributor to cytokine storm interplay; negative regulate T cell by increasing the exhaustion markers |
Body | Impaired hematopoietic function, disseminated intravascular coagulation, debilitating, hyperlipidemia, flu-like symptoms | (4, 6, 8, 9, 28, 36, 37, 66, 68–72, 77–80, 86, 91, 98, 101, 105, 106) |
Lung | Alveolar edema, proteinaceous exudates, desquamation of pneumocytes, ARDS | ||||
Liver | Liver damage | ||||
Chemokines | |||||
CCLX | Macrophage, monocyte, activated T cell, dendritic cell, alveolar epithelial cell | CXCL9, CXCL10, CXCL11, CCL2, CCL3, CCL4, CCL7, CCL8, CCL20, CXCL6, CCL5, and IL-8 are upregulated in COVID-19 | Lung | ARDS | (4, 6, 8, 9, 68, 77, 96, 107) |
CXCL10 | Macrophage, dendritic cell, Th2 cell | Interferon γ-inducible chemokine; recruitment of macrophages, Th1 cells, NK cells Positively correlates with Murray score, viral load, and disease severity; increased levels strongly indicate Th1 cell activation |
Lung | ARDS | (9, 68, 70, 71, 77, 79, 91, 98, 108) |
IL-8 | Macrophage, monocyte, epithelial cell, endothelium cell | Recruits neutrophils Associates with severity of disease in COVID-19 |
Lung | ARDS | (4, 9, 37, 77, 79, 91, 109) |
GM-CSF | Macrophage, monocyte, activated T cell, epithelial cell | Proinflammatory cytokine, stimulating proinflammatory cytokines and chemokines Associated with Th17 responses; GM-CSF secretion of immune cells (CD4+ T cells, CD8+ T cells, NK cells, and B cells) significantly higher |
Lung | ARDS | (4, 6, 9, 36, 70, 77–79, 96, 110–112) |
Liver | Increased acute-phase protein |